Takeda Oncology

BioLife Plasma Services

Takeda Canada Inc.

TAKEDA IBDpoint

Innovation Capability Center at Takeda

Dengue Academy

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities.

PvP Biologics

Alnylam Pharmaceuticals

Xenon Pharmaceuticals

Avidity Biosciences

Ultragenyx Pharmaceutical

Maverick Therapeutics

Mersana Therapeutics

Molecular Templates

Naurex

Seagen

Bill & Melinda Gates Foundation

Takeda

Update em Medicina 2017

EFOMV 2018

YES Meeting 2018

APIC - Reunião Anual 2016

Congresso Português de Hepatologia

TEDx University of Porto

GS1 in EU - REGIONAL FORUM 2016

Tummy Trends

Congresso Hepatologia 2018

Update em Medicina 2018

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Google Maps

Content Delivery Network

Co-Owner

Adrian Łukaszewicz

VP, Head Region US - Oncology and External Supply Small Molecule

Alex Parker

Head of HR and Communications, Member of the Board Austria

Alexandra Hilgers

Computerized System Owner / Global Quality Systems

Andreas Hengstberger

Owner, Instructor

Anne Decker-Beck

Associate Director Global Artwork Processes Owner

Annette Dohmen

Vice President, ABDİBİO & Executive Board Member at Abdi Ibrahim Pharmaceuticals

Aydin Ozuer

Founder/ Owner

Cole Hagen

Director & CFO

Costa Saroukos

Senior Service Owner

Ermis Makis

Jean-Luc Butel

Tadataka Yamada

Emiko Higashi

Sidney Taurel

Jason Marchant

Rekha Paleyanda

Director

Schuyler Fairfield

SVP, Global Head of Supply Chain

Henry Werner

Communication Director Nordics & Baltics

Christopher Barr

Takeda Community Engagement

Bin Li

Director of Computational Biology, Takeda Data Science Institute

Yasuchika Hasegawa

Chairman of the Board & CEO

Masaru Otsuka

Head of Digital Acceleration

Patrycja Lakomiak

Head Of Supply Chain Coordination

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

Turnstone Biologics is a privately-held clinical stage biotech company.

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.

Seagen is a clinical-stage biotechnology company dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.

PvP Biologics is developing an oral enzyme for the treatment of celiac disease.

Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

Investors Active in Midwestern US

Companies With More Than $1M in Revenue (Top 10K)

Asia Companies (Top 10K)

Investors Active in Washington DC Metro Area

Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.

Grant - Takeda

Tokyo

Japan

Asia

Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer (TAK)

Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

California dengue cases prompt swift response from public health officials

Takeda cuts more jobs in U.S. and Japan amid slow growth

Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on

Takeda terminates deal with Wave

NICE turns down Takeda colorectal cancer drug

Tempus teams withTakeda to leverage multimodal real-world datasets in oncology

Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla

Takeda develops treatments for gastrointestinal diseases and inflammatory conditions.

Takeda focuses on creating therapies for rare diseases, addressing unmet medical needs.

Takeda offers therapies derived from plasma to treat various conditions.

Takeda researches and develops cancer treatments.

Takeda provides treatments for neurological disorders.

Takeda develops vaccines to prevent infectious diseases.

United States

North America

India

Austria

Europe

United Kingdom

HTML5

Bootstrap

Apache Server

Cloudflare CDN

Google Drive

Facebook Comments

Comodo PositiveSSL Certificates

Adobe Fonts

Google Fonts

Takeda owns Takeda Ventures

Takeda owns Takeda Consumer Healthcare

Takeda owns Takeda Cambridge

Takeda owns Takeda California

Nipro Corporation is a Japanese company engaged in the development and production of medical devices and pharmaceutical products.

Nipro Corporation

Grifols is a Spanish multinational pharmaceutical and chemical company that specializes in the production of blood plasma-based products.

Grifols

Codiak Biosciences is a biotechnology company focused on the development of exosome-based therapeutics.

Codiak Biosciences

Amgen is an American multinational biopharmaceutical company that focuses on the development of innovative medicines for serious illnesses.

Amgen

Novartis is a Swiss multinational pharmaceutical company known for its research and development of innovative healthcare products.

Novartis

GSK, also known as GlaxoSmithKline, is a British multinational pharmaceutical company that focuses on the development of vaccines, medicines, and consumer healthcare products.

Pfizer is an American multinational pharmaceutical corporation known for its wide range of pharmaceutical products and vaccines.

Pfizer

Janssen, a subsidiary of Johnson & Johnson, is a global pharmaceutical company known for its research and development of innovative healthcare solutions.

Janssen

AbbVie is an American biopharmaceutical company known for its focus on developing advanced therapies for various medical conditions.

AbbVie

UCB is a multinational biopharmaceutical company that specializes in the research and development of treatments for severe diseases.

AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company known for its focus on developing innovative medicines in various therapeutic areas.

AstraZeneca

EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, known for its focus on developing innovative therapies for patients with unmet medical needs.

EMD Serono

Bayer is a German multinational pharmaceutical and life sciences company known for its wide range of healthcare and agricultural products.

Bayer

Sanofi is a French multinational pharmaceutical company known for its focus on developing healthcare solutions in various therapeutic areas.

Sanofi

CSL Limited is an Australian multinational biotechnology company known for its focus on developing and delivering innovative biotherapies and influenza vaccines.

Novo Nordisk is a Danish multinational pharmaceutical company known for its focus on diabetes care and other serious chronic conditions.

Novo Nordisk

Octapharma is a Swiss-based global healthcare company known for its focus on developing and providing high-quality human proteins.

Octapharma

Roche is a Swiss multinational healthcare company known for its focus on innovative pharmaceuticals and diagnostics.

Roche

Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on developing and delivering transformative therapies for patients with rare and special unmet medical needs.

Sanofi Genzyme

Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company known for its focus on developing innovative medicines for serious diseases.

Eli Lilly and Company is an American pharmaceutical company known for its focus on developing and delivering innovative medicines in various therapeutic areas.

Lilly

Gilead Sciences is an American biopharmaceutical company known for its focus on developing and delivering innovative treatments for life-threatening diseases.

Gilead

Teva Pharmaceutical Industries is an Israeli-American multinational pharmaceutical company known for its focus on developing and providing generic and specialty medicines.

TEVA

Abbott Laboratories is an American multinational medical devices and healthcare company known for its wide range of medical devices, diagnostics, and nutrition products.

Abbott

Mylan, now part of Viatris, is a global pharmaceutical company known for its focus on developing and delivering high-quality medicines to patients around the world.

Mylan

Takeda is a global, values-based, R&D-driven biopharmaceutical leader with a large U.S. presence. The company is committed to creating better health for people and a brighter future for the world through transformative treatments and a focus on diversity, equity, and inclusion.

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab, Alofisel, Dexilant, Natpara, Adynovate/Adynovi, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Velcade, Leuplin/Enantone, Adcetris, Vyvansese, Trintellix, and Alunbrig brands. Takeda Pharmaceutical Company Limited has out-licensing agreement with Neurocrine Biosciences, Inc.; collaborations and in-licensing agreements with the University of Texas MD Anderson Cancer Center, Arrowhead Pharmaceuticals Inc., and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, Selecta Biosciences, BridGene Biosciences, Skyhawk Therapeutics, and StrideBio; and strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.

news impact assignment basic	general	Mar 7, 2024 3:34 PM	50fe2e49
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 3:34 PM	82c13344
company summary	general
signals	general	Mar 7, 2024 3:34 PM	140be5f4
crunchbase trigger	general	Nov 22, 2024 7:44 AM	90191c14
crunchbase profile	general	Nov 22, 2024 8:50 AM	94eeadfa
li profile	general	Mar 7, 2024 3:34 PM	fa9f198d
translate crunchbase fundingrounds	general	Nov 22, 2024 10:58 AM	93373342
peers	general	Mar 7, 2024 3:34 PM	ccc4b735
news basic	general	Mar 7, 2024 3:34 PM	5710dc29
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:TAKEDA

Takeda Pharmaceutical Company Limited

Last Close

4,113.00

25/11 06:45

Market Cap

6.77T

Beta: -

Volume Today

9.61M

Avg: -